Free Trial
OTCMKTS:PVCT

Provectus Biopharmaceuticals (PVCT) Stock Price, News & Analysis

Provectus Biopharmaceuticals logo
$0.09 +0.00 (+5.03%)
As of 08/1/2025 12:45 PM Eastern

About Provectus Biopharmaceuticals Stock (OTCMKTS:PVCT)

Key Stats

Today's Range
$0.08
$0.09
50-Day Range
$0.07
$0.10
52-Week Range
$0.04
$0.15
Volume
54,200 shs
Average Volume
175,365 shs
Market Capitalization
$38.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PVCT Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
Provectus announces $3M seed financing round for VisiRose
Provectus announces the launch of VisiRose
See More Headlines

PVCT Stock Analysis - Frequently Asked Questions

Provectus Biopharmaceuticals' stock was trading at $0.1201 on January 1st, 2025. Since then, PVCT shares have decreased by 23.5% and is now trading at $0.0919.

Shares of PVCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provectus Biopharmaceuticals investors own include Vertex Energy (VTNR), Good Times Restaurants (GTIM), Merck & Co., Inc. (MRK), Oncolytics Biotech (ONC), American Superconductor (AMSC), Cannabis Science (CBIS) and (DARA) (DARA).

Company Calendar

Today
8/02/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PVCT
Previous Symbol
NYSEMKT:PVCT
CIK
315545
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.76 million
Net Margins
-815.81%
Pretax Margin
-823.71%
Return on Equity
N/A
Return on Assets
-644.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.11
Quick Ratio
0.11

Sales & Book Value

Annual Sales
$620 thousand
Price / Sales
62.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-9.19

Miscellaneous

Outstanding Shares
420,280,000
Free Float
358,499,000
Market Cap
$38.62 million
Optionable
Not Optionable
Beta
0.57

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:PVCT) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners